HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
PCRX holding history
Pacira BioSciences, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −200−100.0% | Sold out | Holders |
| Q1 2022 | 200 | $15.0K | <0.1% | −450−69.2% | Reduced | Holders |
| Q4 2021 | 650 | $39.0K | <0.1% | −600−48.0% | Reduced | Holders |
| Q3 2021 | 1,250 | $70.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,250 | $76.0K | <0.1% | +1,200+2,400.0% | Added | Holders |
| Q1 2021 | 50 | $4.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.